The risk of patient cross-contamination from Venturi-Principle atomizers

Wolfe, T.R.

Orl-Head and Neck Nursing Official Journal of the Society of Otorhinolaryngology and Head-Neck Nurses 23(2): 25-27

2005


ISSN/ISBN: 1064-3842
PMID: 15916354
Document Number: 587939
Otolaryngology clinicians care for numerous immunocompetent and immunosuppressed patients with transmissible bacterial, viral and fungal infections, including serious pathogens, such as methicillin resistant Staphylococcus aureus (MRSA), tuberculosis (TB), and human immunodeficiency virus (HIV). In addition, otolaryngology clinicians commonly use a device to deliver topical anesthetics and decongestants to the nose and throat with a known potential to cross-contaminate patients, the air-driven DeVilbiss atomizer, which operates according to the Venturi principle. This article will review the mechanism of action of the air-driven atomizer and discuss the literature which demonstrates the associated a risk for patient cross-contamination.

Document emailed within 1 workday
Secure & encrypted payments